Paul A. Corris

Summary

Paul A. Corris. Role: unknown. No source read in this review states the role of this author. Field: unknown. Affiliation: unknown (marked missing). Basis: unverified; OpenAlex lists "Newcastle University" on the most recent corpus paper (2025). Not confirmed as current.. The whole-count rank depends substantially on consensus or guideline papers. Counts in the OpenAlex corpus (retrieved 2026-10-10): 7 papers and 1,134 citations over ten years; 0 first-author and 3 last-author papers. Ranks: main 17, excluding consensus papers 215, first or last author 80. The method is stated once on the People list page. Linked papers are the most-cited corpus papers of this author.

Citation ranks (10 years)

Citations: 1,134 in total, 182 excluding consensus and guideline papers (1 of this author's papers excluded), 101 on first or last author papers (0 first, 3 last).

Role and field

Role

unknown

Role status

unknown (no source read in this review states the role)

Field

unknown

Field basis

no unit name found in the sources read

Only what a cited source supports is stated. Entries marked self-asserted come from the person's own ORCID record. The field is taken from the name of the unit, not inferred from the person's name.

Details

papers 10y

7

fractional papers 10y

1.06

citations 10y

1134

fractional citations 10y

104.1

ranking retrieved

2026-10-10

openalex author id

A5058197659

merged open alex profiles

2

affiliation basis

unverified; OpenAlex lists "Newcastle University" on the most recent corpus paper (2025). Not confirmed as current.

papers excluding consensus 10y

6

citations excluding consensus 10y

182

consensus papers excluded 10y

1

first author papers 10y

0

last author papers 10y

3

lead author citations 10y

101

lead author papers 10y

3

Sources and links

• OpenAlex author profile (primary)
• Most-cited CLAD paper in corpus: Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT (The Journal of Heart and Lung Transplantation, 2019); 952 citations; DOI 10.1016/j.healun.2019.03.009
• Most-cited CLAD paper in corpus: Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation (Transplantation, 2018); 63 citations; DOI 10.1097/tp.0000000000002168
• Most-cited CLAD paper in corpus: A European Multi‐Center, Randomized, Double‐Blind Trial of Pirfenidone in Bronchiolitis‐Obliterans‐Syndrome Grade 1‐3 in Lung Transplant Recipients (European Trial of Pirfenidone in BOS (EPOS)) (The Journal of Heart and Lung Transplantation, 2020); 13 citations; DOI 10.1016/j.healun.2020.01.1130
• Most-cited CLAD paper in corpus: A European multicentre, randomised controlled trial of pirfenidone in bronchiolitis obliterans syndrome after bilateral lung transplantation (European Respiratory Journal, 2026); 9 citations; DOI 10.1183/13993003.02154-2024

Related

Links from this record

• author: Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment: A consensus report from the Pulmonary Council of the ISHLT
• author: A European multicentre, randomised controlled trial of pirfenidone in bronchiolitis obliterans syndrome after bilateral lung transplantation

Known gaps in this record

• role or job title
• centre membership relation (not asserted)
• funding and conflicts of interest
• verified current affiliation
• ORCID
• whole-count rank depends substantially on consensus or guideline papers; see the rank excluding consensus papers
• whole-count rank depends substantially on consensus or guideline papers; see the rank excluding consensus papers